MSTP at Mayo Clinic Rochester
罗切斯特梅奥诊所的 MSTP
基本信息
- 批准号:10409857
- 负责人:
- 金额:$ 116.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
The mission of the Mayo Clinic Medical Scientist Training Program (MSTP) is to train clinician-scientist leaders
of the future. Our program is designed to mentor a diverse group of trainees whom we individually guide on
their journeys to develop the technical, operational, and professional skills to support a productive career in
which they integrate research and clinical activities to advance biomedical science. In order to fulfill our mission
of developing these future clinician-scientist leaders, we propose four measurable objectives that will serve as
the foundation of our program: 1) To provide a fully integrated scientific and clinical training program that will
help trainees develop the skills needed to recognize and address important clinical problems while
simultaneously enabling our graduates to move easily between research and clinical environments; 2) To
develop a diverse group of future leaders who possess the self-confidence and communication skills to share
scientific concepts with colleagues and individuals at all scientific levels as well as scientific and political leaders;
3) To encourage trainees to develop self-reflective skills that will lead to rigor in their own science and recognition
of instances where rigor and reproducibility tenets may be lacking; and 4) To provide trainees with experiences
that reflect their own long-term scientific goals in academia or other careers. This MSTP admits nine MD-PhD
trainees per year from a pool of over three hundred applicants. Ninety-six carefully vetted and trained laboratory
mentors will provide a safe learning environment and guide rigorous research. The co-Directors, Drs. Schimmenti
and Kaufmann, have over thirty years of combined experience in MD-PhD leadership and are committed to the
success and well-being of every trainee. Under-represented trainees make up seventeen percent of the trainee
cohort, with planned enrollment of twenty percent at the end of the 2021 admissions season. Mayo Clinic’s three-
part mission comprised of patient care, research, and education, provides a rich environment for training. The
average time to degree for the last ten years of graduates is 8.18 years, with a mean of 4.3 first author papers
per trainee and 8.7 total papers per trainee. Trainees are required to submit an F award or equivalent; and the
success rate over the last ten years has been 58%. Trainees match well, with three of five trainees matching in
physician scientist training programs in 2021. A self-reflective iterative evaluation process has been developed
and implemented to support cycles of program improvement with goals to support rigor and reproducibility
training, trainee retention, a diverse learning community, decreased time to degree, scholarship, and career
satisfaction. The long-term goal of the program is to provide each dual-degree graduate a firm foundation for a
lifetime of career success in research and research related fields.
项目摘要
梅奥诊所医学科学家培训计划(MSTP)的任务是培训临床科学家领导者
未来。我们的计划旨在指导我们分别指导的潜水者团体
他们的旅程发展技术,运营和专业技能,以支持富有成效的职业
他们整合研究和临床活动以提高生物医学科学。为了履行我们的使命
通过发展这些未来的临床科学家领导者,我们提出了四个可衡量的目标
我们计划的基础:1)提供完全整合的科学和临床培训计划
帮助学员发展识别和解决重要临床问题所需的技能
同时使我们的毕业生能够在研究和临床环境之间轻松移动; 2)到
培养拥有自信和沟通能力的一群未来领导者群体分享
在各个科学层面以及科学和政治领导人的科学概念以及个人的科学概念;
3)鼓励学员发展自我反思技能,这将导致自己的科学和认可方面的严格性
在可能缺乏严格和可重复性宗旨的情况下; 4)为学员提供经验
这反映了他们在学术界或其他职业中的长期科学目标。这个MSTP接纳了9个MD-PHD
每年有三百多名申请人的受训者。九十六个精心审查和训练有素的实验室
导师将提供安全的学习环境,并指导严格的研究。联合导演,博士。 Schimmenti
和考夫曼(Kaufmann),在MD-PHD领导领导中拥有30多年的综合经验,并致力于
每个学员的成功和福祉。代表不足的实习生占学员的17%
队列,计划在2021年招生季节结束时招收20%。梅奥诊所的三
一部分任务完成了患者护理,研究和教育,为培训提供了丰富的环境。这
毕业生最近十年的平均学位时间为8。18年,平均为4.3第一作者论文
每学员,每位学员总论文8.7。学员必须提交F奖或同等学历;和
过去十年中的成功率为58%。学员匹配良好,五名实习生中有三名在
物理科学家培训计划于2021年。已经开发了自我反射的迭代评估过程
并实施以支持计划改进的循环,以支持严格和可重复性的目标
培训,学员保留,一个不同的学习社区,减少了学位,科学和职业的时间
该计划的长期目标是为每个双级毕业生提供一个牢固的基础
研究和研究与研究领域的职业成功寿命。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Biventricular catheterization combined with pressure-volume loop monitoring provides insight into the dynamic effects of left ventricular assist devices ramp on right ventricular function.
双心室导管插入术与压力-容量环路监测相结合,可以深入了解左心室辅助装置斜坡对右心室功能的动态影响。
- DOI:10.1002/ccd.30993
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Garmany,Armin;Inglis,SaraS;Behfar,Atta;Rosenbaum,AndrewN
- 通讯作者:Rosenbaum,AndrewN
Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy.
- DOI:10.1038/s41598-023-40795-1
- 发表时间:2023-09-01
- 期刊:
- 影响因子:4.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT H KAUFMANN其他文献
SCOTT H KAUFMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT H KAUFMANN', 18)}}的其他基金
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10438886 - 财政年份:2021
- 资助金额:
$ 116.11万 - 项目类别:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10296087 - 财政年份:2021
- 资助金额:
$ 116.11万 - 项目类别:
Cause and therapeutic impact of DNA-protein crosslink repair defect in myeloid leukemias
髓系白血病 DNA-蛋白质交联修复缺陷的原因和治疗影响
- 批准号:
10656207 - 财政年份:2021
- 资助金额:
$ 116.11万 - 项目类别:
BAK Autoactivation in Hematological Malignancies
血液系统恶性肿瘤中的 BAK 自动激活
- 批准号:
10425322 - 财政年份:2020
- 资助金额:
$ 116.11万 - 项目类别:
BAK Autoactivation in Hematological Malignancies
血液系统恶性肿瘤中的 BAK 自动激活
- 批准号:
10188459 - 财政年份:2020
- 资助金额:
$ 116.11万 - 项目类别:
BAK Autoactivation in Hematological Malignancies
血液系统恶性肿瘤中的 BAK 自动激活
- 批准号:
10684892 - 财政年份:2020
- 资助金额:
$ 116.11万 - 项目类别:
Deubiquitinases in regulation of BRCA1 pathway
去泛素酶对 BRCA1 通路的调节
- 批准号:
10006119 - 财政年份:2016
- 资助金额:
$ 116.11万 - 项目类别:
Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
卵巢癌 PARP 抑制剂耐药机制
- 批准号:
9020939 - 财政年份:2015
- 资助金额:
$ 116.11万 - 项目类别:
Anticancer drug-induced BH3-only protein.Bak interactions
抗癌药物诱导的 BH3-only 蛋白.Bak 相互作用
- 批准号:
8273913 - 财政年份:2012
- 资助金额:
$ 116.11万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
支持二维毫米波波束扫描的微波/毫米波高集成度天线研究
- 批准号:62371263
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
腙的Heck/脱氮气重排串联反应研究
- 批准号:22301211
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水系锌离子电池协同性能调控及枝晶抑制机理研究
- 批准号:52364038
- 批准年份:2023
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于人类血清素神经元报告系统研究TSPYL1突变对婴儿猝死综合征的致病作用及机制
- 批准号:82371176
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 116.11万 - 项目类别:
Advancing entirely virus-free CRISPR CAR T cells to clinic- Are they as good as lentiviral CAR?
将完全无病毒的CRISPR CAR T细胞推向临床——它们和慢病毒CAR一样好吗?
- 批准号:
MR/Y503496/1 - 财政年份:2024
- 资助金额:
$ 116.11万 - 项目类别:
Research Grant
De Montfort University and Edward C. Buckwald Limited, t/a Abbots Langley Clinic KTP 23_24 R2
德蒙福特大学和 Edward C. Buckwald Limited,t/a Abbots Langley Clinic KTP 23_24 R2
- 批准号:
10078961 - 财政年份:2024
- 资助金额:
$ 116.11万 - 项目类别:
Knowledge Transfer Partnership
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 116.11万 - 项目类别:
Identifying mechanisms and novel treatments of bone pain - closing the gap to the clinic. BonePainIII
确定骨痛的机制和新疗法——缩小与临床的差距。
- 批准号:
EP/Y036956/1 - 财政年份:2024
- 资助金额:
$ 116.11万 - 项目类别:
Research Grant